Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
Baxter
McKinsey
Medtronic
Johnson and Johnson

Last Updated: January 18, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Nemonoxacin

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the development status for investigational drug Nemonoxacin?

Nemonoxacin is an investigational drug.

There have been 12 clinical trials for Nemonoxacin. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2011.

The most common disease conditions in clinical trials are Pneumonia, Infection, and Focal Infection. The leading clinical trial sponsors are TaiGen Biotechnology Co., Ltd., Zhejiang Medicine Co., Ltd., and Qualitix Clinical Research Co., Ltd.

There are ten US patents protecting this investigational drug and one hundred and twenty-seven international patents.

Recent Clinical Trials for Nemonoxacin
TitleSponsorPhase
Pharmacokinetics Study of Nemonoxacin Malate Capsules in Subjects With Severe Impaired Renal FunctionZhejiang Medicine Co., Ltd.Phase 1
An International, Multicenter, Randomized, Double-blind, Double-dummy, Two-way, Parallel Group, Controlled Study to Compare the Efficacy and Safety of Intravenous and Oral Nemonoxacin Versus TavanicĀ® in Adult Patients With Community-acquired PneumoOCT Clinical TrialsPhase 3
An International, Multicenter, Randomized, Double-blind, Double-dummy, Two-way, Parallel Group, Controlled Study to Compare the Efficacy and Safety of Intravenous and Oral Nemonoxacin Versus TavanicĀ® in Adult Patients With Community-acquired PneumoR-PharmPhase 3

See all Nemonoxacin clinical trials

Clinical Trial Summary for Nemonoxacin

Top disease conditions for Nemonoxacin
Top clinical trial sponsors for Nemonoxacin

See all Nemonoxacin clinical trials

US Patents for Nemonoxacin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Nemonoxacin   Start Trial Oxidative coupling of aryl boron reagents with SP3-carbon nucleophiles, and ambient decarboxylative arylation of malonate half-esters via oxidative catalysis The Governors of the University of Alberta (Edmonton, CA)   Start Trial
Nemonoxacin   Start Trial Antimicrobial quinolones, their compositions and uses The Procter & Gamble Co. (Cincinnati, OH)   Start Trial
Nemonoxacin   Start Trial Coupling process for preparing quinolone intermediates The Procter & Gamble Company (Cincinnati, OH)   Start Trial
Nemonoxacin   Start Trial Antimicrobial quinolones, their compositions, and uses The Procter & Gamble Company (Cincinnati, OH)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Nemonoxacin

Drugname Country Document Number Estimated Expiration Related US Patent
Nemonoxacin Canada 2953669 2037-01-05   Start Trial
Nemonoxacin Argentina 013493 2017-09-15   Start Trial
Nemonoxacin Austria 423776 2017-09-15   Start Trial
Nemonoxacin Australia 735186 2017-09-15   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
McKesson
Moodys
McKinsey
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.